Serology and bacteriology in reactive arthritis

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.

Annals of the rheumatic diseases·2003

Chloroquine therapy in patients with recent-onset rheumatoid arthritis: the clinical response can be predicted by the low level of acute-phase reaction at baseline.

Clinical rheumatology·1999

Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss.

Rheumatology (Oxford, England)·1999

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.

Arthritis and rheumatism·1998

Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.

The Journal of rheumatology·1998

A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.

Osteoarthritis and cartilage·1997

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Annals of the rheumatic diseases·2026

Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.

Annals of the rheumatic diseases·2026

Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.

Annals of the rheumatic diseases·2026

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Annals of the rheumatic diseases·2026

Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.

Annals of the rheumatic diseases·2026

Development and validation of minimal disease activity, disease flare, and minimal clinically important difference for children with chronic nonbacterial osteomyelitis using a consensus and data-driven approach.

Annals of the rheumatic diseases·2026

The Audiologic and Otolaryngologic Phenotype in WHIM Syndrome.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026

Incidence of Chronic Rhinosinusitis in Patients Who Receive Rituximab.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026

From Sight to Stridor: Recurrent Angioedema in Systemic Lupus Erythematosus Associated With Complement Activation.

The American journal of case reports·2026

Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection.

Immunology and cell biology·2026

A Delphi-method-based consensus for clinical domains and assessment of the inflammatory subtype of major depressive disorder from the ASPIRE study.

Brain, behavior, and immunity·2026

Innate Immune System Biomarkers in Asthma in Older Age: A Mini Review.

Archives of Iranian medicine·2026

Related Experiment Videos

Serology and bacteriology in reactive arthritis

Related Concept Videos

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.

Chloroquine therapy in patients with recent-onset rheumatoid arthritis: the clinical response can be predicted by the low level of acute-phase reaction at baseline.

Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss.

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.

Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.

A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.

Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.

Development and validation of minimal disease activity, disease flare, and minimal clinically important difference for children with chronic nonbacterial osteomyelitis using a consensus and data-driven approach.

The Audiologic and Otolaryngologic Phenotype in WHIM Syndrome.

Incidence of Chronic Rhinosinusitis in Patients Who Receive Rituximab.

From Sight to Stridor: Recurrent Angioedema in Systemic Lupus Erythematosus Associated With Complement Activation.

Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection.

A Delphi-method-based consensus for clinical domains and assessment of the inflammatory subtype of major depressive disorder from the ASPIRE study.

Innate Immune System Biomarkers in Asthma in Older Age: A Mini Review.

Related Experiment Videos

Serology and bacteriology in reactive arthritis

Related Concept Videos

Related Articles